Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca - BioSpace
2026-03-24 - 13:30
Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca BioSpace
Share this post:
2026-03-24 - 13:30
Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca BioSpace